These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37476552)

  • 1. Retracted: PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment.
    Oncology JO
    J Oncol; 2023; 2023():9839681. PubMed ID: 37476552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment.
    Wang L; Deng X; Chen Y; Zhao Y; Li Z
    J Oncol; 2022; 2022():3290479. PubMed ID: 36157240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer.
    International BR
    Biomed Res Int; 2024; 2024():9789013. PubMed ID: 38550155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: circFAT1(e2) Promotes Papillary Thyroid Cancer Proliferation, Migration, and Invasion via the miRNA-873/ZEB1 Axis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9820923. PubMed ID: 37885876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer.
    Mao M; Huang RZ; Zheng J; Liang HQ; Huang WH; Liu J; Li JH
    Cancer Med; 2021 Jan; 10(2):728-736. PubMed ID: 33405394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Ultrasonic Intelligent Diagnosis of Papillary Thyroid Carcinoma Based on Machine Learning.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9854690. PubMed ID: 38078171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: PLK1 Is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma.
    International BR
    Biomed Res Int; 2023; 2023():9846745. PubMed ID: 37388346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Meta-Analysis of the Application Effect of Different Modalities of Thermal Ablation and Surgical Treatment in Papillary Thyroid Microcarcinoma.
    Markers D
    Dis Markers; 2023; 2023():9819468. PubMed ID: 38077933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Risk Factors for TERT Promoter Mutations with Papillary Thyroid Carcinoma Patients: A Meta-Analysis and Systematic Review.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9781303. PubMed ID: 38094448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9893453. PubMed ID: 37387739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding RNAs in Papillary Thyroid Cancer: Interaction with Cancer-Associated Fibroblasts (CAFs) in the Tumor Microenvironment (TME) and Regulators of Differentiation and Lymph Node Metastasis.
    Dadafarin S; Carnazza M; Islam HK; Moscatello A; Tiwari RK; Geliebter J
    Adv Exp Med Biol; 2021; 1350():145-155. PubMed ID: 34888848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9870383. PubMed ID: 37621621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer.
    Oncology JO
    J Oncol; 2023; 2023():9807856. PubMed ID: 37946722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9787264. PubMed ID: 37810555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction Notice to: Circular RNA Profiling Reveals Exosomal circ_0006156 as a Novel Biomarker in Papillary Thyroid Cancer.
    Wu G; Zhou W; Pan X; Sun Z; Sun Y; Xu H; Shi P; Li J; Gao L; Tian X
    Mol Ther Nucleic Acids; 2022 Jun; 28():572. PubMed ID: 35592506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9761231. PubMed ID: 37388089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
    International BR
    Biomed Res Int; 2024; 2024():9848746. PubMed ID: 38550141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.
    International BR
    Biomed Res Int; 2024; 2024():9824604. PubMed ID: 38549965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary Adenoma.
    Journal Of Oncology
    J Oncol; 2023; 2023():9813986. PubMed ID: 37476559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.